Sugammadex: a novel neuromuscular blocker binding agent
作者： Aaron M Fields , Nalini Vadivelu
DOI: 10.1097/ACO.0B013E32814B1612
关键词:
摘要: Purpose of reviewSugammadex is a novel drug that binds selected neuromuscular blocking drugs and prevents them from acting at the junction. Due to its rapid onset relative lack side effects, this promises change method anesthesia delivery. This review summarizes t
sci-hub.se 参考文章(16)
Thomas M. Hemmerling, Nhien Le, Brief review: Neuromuscular monitoring: an update for the clinician. Canadian Journal of Anaesthesia-journal Canadien D Anesthesie. ,vol. 54, pp. 58- 72 ,(2007) , 10.1007/BF03021901
Hans D. de Boer, Jan van Egmond, Francien van de Pol, Anton Bom, Leo H. D. J. Booij, Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized rhesus monkeys. Anesthesiology. ,vol. 104, pp. 718- 723 ,(2006) , 10.1097/00000542-200604000-00016
P. Schultz, M. Ibsen, D. Østergaard, L. T. Skovgaard, Onset and duration of action of rocuronium--from tracheal intubation, through intense block to complete recovery. Acta Anaesthesiologica Scandinavica. ,vol. 45, pp. 612- 617 ,(2001) , 10.1034/J.1399-6576.2001.045005612.X
Anton Bom, Mark Bradley, Ken Cameron, John K. Clark, Jan van Egmond, Helen Feilden, Elizabeth J. MacLean, Alan W. Muir, Ronald Palin, David C. Rees, Ming-Qiang Zhang, A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin-Based Synthetic Host The discovery of Org 25969 is the result of teamwork with contributions from a number of scientists both inside Organon and outside the company. We would like in particular to acknowledge the following scientists for their invaluable contributions: E. Hutchinson, D. Stevenson, R. Roy, and J. Pick for scaling-up the synthesis; F. Hope, S. Miller, and R. Mason for various in vitro and in vivo pharmacological testing; R. Watson, B. Montgomery, P. Desmond, and A. Osprey for all their analytical effort; and R. McGuire and J. Mestres for graphical presentation of the X-ray crystal structure of the Org 25969–rocuronium complex (Figure 3). We would also like to thank Prof. A. Cooper of Glasgow University who has critically reproduced our calorimetry data of Org 25969–rocuronium complexation (Figure 2). Angewandte Chemie International Edition. ,vol. 41, pp. 265- 270 ,(2002) , 10.1002/1521-3773(20020118)41:2<265::AID-ANIE265>3.0.CO;2-Q
Julia M. Adam, D. Jonathan Bennett, Anton Bom, John K. Clark, Helen Feilden, Edward J. Hutchinson, Ronald Palin, Alan Prosser, David C. Rees, Georgina M. Rosair, Donald Stevenson, Gary J. Tarver, Ming-Qiang Zhang, Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. Journal of Medicinal Chemistry. ,vol. 45, pp. 1806- 1816 ,(2002) , 10.1021/JM011107F
Gabriella Bettelli, Which muscle relaxants should be used in day surgery and when. Current Opinion in Anesthesiology. ,vol. 19, pp. 600- 605 ,(2006) , 10.1097/ACO.0B013E32801062EB
Koen Suy, Karl Morias, Guy Cammu, Pol Hans, Wilbert G. F. van Duijnhoven, Marten Heeringa, Ignace Demeyer, Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology. ,vol. 106, pp. 283- 288 ,(2007) , 10.1097/00000542-200702000-00016
Andrzej J Piotrowski, Wojciech M Fendler, None, Hyperkalemia and cardiac arrest following succinylcholine administration in a 16-year-old boy with acute nonlymphoblastic leukemia and sepsis Pediatric Critical Care Medicine. ,vol. 8, pp. 183- 185 ,(2007) , 10.1097/01.PCC.0000257103.96579.B2
Francois Gijsenbergh, Steven Ramael, Natalie Houwing, Thijs van Iersel, First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide Anesthesiology. ,vol. 103, pp. 695- 703 ,(2005) , 10.1097/00000542-200510000-00007
Ola Epemolu, Iain Mayer, Frank Hope, Paul Scullion, Paul Desmond, Liquid chromatography/mass spectrometric bioanalysis of a modified γ‐cyclodextrin (Org 25969) and Rocuronium bromide (Org 9426) in guinea pig plasma and urine: its application to determine the plasma pharmacokinetics of Org 25969 Rapid Communications in Mass Spectrometry. ,vol. 16, pp. 1946- 1952 ,(2002) , 10.1002/RCM.812